Clinical Trials
3 trialsNCT01755195 2024-01-03
Cabozantinib for Adults With Advanced Soft Tissue Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04661852 2023-02-15
Cabozantinib With Topotecan-Cyclophosphamide
Dana-Farber Cancer Institute
Phase 1 Completed
NCT02216578 2021-07-15
Ph II CABOGIST in GIST
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed